FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3638211000001100: Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17508901000001118 Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
68748701000001110 Neo-Naclex-K modified-release tablets (Mercury Pharma Group Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Is a Bendrofluazide+potassium 2.5mg/8.4Mmol m/r tablet false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has active ingredient Potassium true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has active ingredient Bendrofluazide - chemical false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Is a Neo-Naclex-K true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has specific active ingredient Potassium chloride true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has specific active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Is a Bendroflumethiazide 2.5mg / Potassium chloride 630mg (potassium 8.4mmol) modified-release tablets false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Is a Bendroflumethiazide 2.5mg / Potassium chloride 630mg (potassium 8.4mmol) modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Is pack of False Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has AMP True Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start